Pharnext
Pharnext's email is contact@pharnext.com
and
Pharnext's phone number is 33 1 55 42 62 00
.
Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology ...
read more
Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).
show less
Website | pharnext.com | |
Industry | Biotechnology | |
Location | France | |
Employees | 56 | |
Founded | 2007 |
HQ | 11-13 rue René Jacques | |
Phone | 33 1 55 42 62 00 | |
contact@pharnext.com | ||
Funding | 157,576,441 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | pharnext.com | |
Industry | Biotechnology | |
Location | France | |
Employees | 56 | |
Founded | 2007 | |
linkedin.com/company/pharnext | ||
HQ | 11-13 rue René Jacques | |
Phone | 33 1 55 42 62 00 | |
contact@pharnext.com | ||
Funding | 157,576,441 USD |
Email Patterns for Pharnext
Top Competitors for Pharnext
Pharnext Questions
Where are Pharnext's headquarters?
Pharnext's headquarters are in 11-13 rue René Jacques
What is Pharnext's phone number?
Pharnext's phone number is 33 1 55 42 62 00
What is Pharnext's official website?
Pharnext's website is pharnext.com
How many employees are working in Pharnext right now?
Pharnext has
56 employees.
View the Email and Phone Numbers for all 56 working at Pharnext.
What is Pharnext's industry?
Pharnext's industry is
Biotechnology
Who are Pharnext's top competitors?
Pharnext's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Pharnext's email address?
Pharnext's email address is contact@pharnext.com
What are Pharnext's categories?
Pharnext's categories are Biopharma, Biotechnology, Medical, Neuroscience, Pharmaceutical
What is Pharnext's location?
Pharnext's location is
France
When was Pharnext's founded?
Pharnext's founding year is 2007
What is Pharnext's funding?
Pharnext's funding is 157,576,441 USD
What is Pharnext's current status?
Pharnext's current status is ipo
Top Pharnext Employees
Chief Medical Officer And Head Of Research And Development
adrianhepner@yahoo.com
+1949-389-6755
Biostatistics Team Leader
+3368-583-1026
Pdg
Chief Executive Officer
dcohen@pharnext.com
Researcher In Systems Biology Chez Pharnext
Responsable Comptable Et Reporting Financier
lbrahiti@pharnext.com
Co Founder And Chief Biology Officer
snabirotchkin@pharnext.com